Wayne F. Pisano, President and Chief Executive Officer
Wayne Pisano joined VaxInnate as interim Chief Executive Officer in January 2012 and as permanent CEO in April 2012. Wayne is the former President and CEO of Sanofi Pasteur, the largest company entirely dedicated to vaccines. Wayne joined Sanofi Pasteur as Vice President, U.S. Marketing in 1997 and held positions of increasing responsibility including Head of Global Commercial Operations and Corporate Strategy. Wayne is credited with leading Sanofi Pasteur into its role as the primary worldwide influenza vaccine manufacturer, with approximately 50 percent of global sales. Along with leading the development and implementation of Sanofi Pasteur’s commercial strategy, Wayne focused the company’s research and development strategy and pipeline on identifying and furthering vaccines to protect against diseases that impact both developed and developing nations. Wayne holds a Bachelor’s degree in Biology from St. John Fisher College, Rochester, New York, and an M.B.A. from the University of Dayton, Ohio.
Kathleen A. McGowan, Chief Financial Officer
Kathleen McGowan joined VaxInnate as Chief Financial Officer in January 2013. Kathleen brings 30 years of diversified financial experience in the pharmaceutical and biotech industry. From 2008-12 she served as the Vice President, Finance, at Tobira, a privately-held biopharmaceutical company developing innovative therapies for treatment of HIV infection. Prior to Tobira, she was Director, Finance and Controller (Chief Accounting Officer) for Discovery Laboratories, Inc., a publicly-held biotech company focused on advancing respiratory critical care. From 2000-04, Kathleen served as Director of Financial Analysis at Claneil Enterprises, Inc., a private equity investment firm. Previously, she served as Financial Controller at The Liposome Company, Inc., a publicly-held biotech company acquired by Elan Corporation, plc, and was Controller at Nelson Communications. From 1983-1995, Kathleen held various financial management positions with Johnson & Johnson, primarily at Ortho-McNeil Pharmaceutical and Johnson & Johnson Corporate. Kathleen received her Bachelor of Science degree in Finance and Accounting from Drexel University and holds an M.B.A. in Finance from Fairleigh Dickinson University.